OpenURL Connection Search

Select item for more details and to access through your institution.

Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study.
Published in:
Rheumatology, 2022, v. 61, n. 12, p. 4797, doi. 10.1093/rheumatology/keac167
By:
- Price, Elizabeth;
- Bombardieri, Michele;
- Kivitz, Alan;
- Matzkies, Franziska;
- Gurtovaya, Oksana;
- Pechonkina, Alena;
- Jiang, Wendy;
- Downie, Bryan;
- Mathur, Anubhav;
- Mozaffarian, Afsaneh;
- Mozaffarian, Neelufar;
- Gottenberg, J Eric
Publication type:
Article
Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study.
Published in:
Rheumatology, 2022, v. 61, n. 6, p. 2413, doi. 10.1093/rheumatology/keab685
By:
- Werth, Victoria P;
- Fleischmann, Roy;
- Robern, Michael;
- Touma, Zahi;
- Tiamiyu, Iyabode;
- Gurtovaya, Oksana;
- Pechonkina, Alena;
- Mozaffarian, Afsaneh;
- Downie, Bryan;
- Matzkies, Franziska;
- Wallace, Daniel
Publication type:
Article
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Published in:
Modern Rheumatology, 2023, v. 33, n. 4, p. 668, doi. 10.1093/mr/roac084
By:
- Tanaka, Yoshiya;
- Matsubara, Tsukasa;
- Atsumi, Tatsuya;
- Amano, Koichi;
- Ishiguro, Naoki;
- Sugiyama, Eiji;
- Yamaoka, Kunihiro;
- Combe, Bernard G.;
- Kivitz, Alan J.;
- Sang-Cheol Bae;
- Keystone, Edward C.;
- Nash, Peter;
- Genovese, Mark;
- Matzkies, Franziska;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Lei Ye;
- Qi Gong;
- Tasset, Chantal
Publication type:
Article
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Published in:
Modern Rheumatology, 2023, v. 33, n. 4, p. 657, doi. 10.1093/mr/roac083
By:
- Atsumi, Tatsuya;
- Tanaka, Yoshiya;
- Matsubara, Tsukasa;
- Amano, Koichi;
- Ishiguro, Naoki;
- Sugiyama, Eiji;
- Yamaoka, Kunihiro;
- Westhovens, René;
- Ching, Daniel W. T.;
- Messina, Osvaldo Daniel;
- Burmester, Gerd R.;
- Genovese, Mark;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Kondo, Akira;
- Zhaoyu Yin;
- Qi Gong;
- Chantal Tasset;
- Takeuchi, Tsutomu
Publication type:
Article
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years.
Published in:
Modern Rheumatology, 2023, v. 33, n. 1, p. 64, doi. 10.1093/mr/roac020
By:
- Naoki Ishiguro;
- Yoshiya Tanak;
- Tsukasa Matsubara;
- Tatsuya Atsumi;
- Koichi Amano;
- Eiji Sugiyama;
- Kunihiro Yamaoka;
- Winthrop, Kevin;
- Kivitz, Alan;
- Burmester, Gerd R.;
- Gottenberg, Jacques-Eric;
- Genovese, Mark C.;
- Matzkies, Franziska;
- Ying Guo;
- Deyuan Jiang;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Besuyen, Robin;
- Tsutomu Takeuchi
Publication type:
Article
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Published in:
Modern Rheumatology, 2022, v. 32, n. 2, p. 273, doi. 10.1093/mr/roab021
By:
- Tatsuya Atsumi;
- Yoshiya Tanaka;
- Tsukasa Matsubara;
- Koichi Amano;
- Naoki Ishiguro;
- Eiji Sugiyama;
- Kunihiro Yamaoka;
- Rene;
- Westhovens;
- Ching, Daniel W.T.;
- Messina, Osvaldo Daniel;
- Burmester, Gerd R.;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Zhaoyu Yin;
- Ying Guo;
- Tasset, Chantal;
- Sundy, John S.;
- Tsutomu Takeuchi
Publication type:
Article
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Published in:
Modern Rheumatology, 2022, v. 32, n. 2, p. 263, doi. 10.1093/mr/roab030
By:
- Yoshiya Tanaka;
- Tsukasa Matsubara;
- Tatsuya Atsumi;
- Koichi Amano;
- Naoki Ishiguro;
- Eiji Sugiyama;
- Kunihiro YamaokaAUS-Department of Rheumatology and Infectious Diseases,Kitasato University School of Medicine, Kanagawa, Japan;
- Combe, Bernard G.;
- Kivitz, Alan J.;
- Sang-Cheol Bae;
- Keystone, Edward C.;
- Nash, Peter;
- Matzkies, Franziska;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Akira Kondo;
- Lei Ye;
- Ying Guo;
- Tasset, Chantal;
- Sundy, John S.
Publication type:
Article
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).
Published in:
Modern Rheumatology, 2022, v. 32, n. 1, p. 59, doi. 10.1080/14397595.2020.1859675
By:
- Tsutomu Takeuchi;
- Tsukasa Matsubara;
- Tatsuya Atsumi;
- Koichi Amano;
- Naoki Ishiguro;
- Eiji Sugiyama;
- Kunihiro Yamaoka;
- Genovese, Mark C.;
- Kalunian, Kenneth;
- Walker, David;
- Gottenberg, Jacques-Eric;
- de Vlam, Kurt;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Kondo, Akira;
- Gao, Jie;
- Ying Guo;
- Tasset, Chantal;
- Sundy, John S.;
- Yoshiya Tanakao
Publication type:
Article
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
Published in:
2023
By:
- Combe, Bernard G.;
- Tanaka, Yoshiya;
- Buch, Maya H.;
- Nash, Peter;
- Burmester, Gerd R.;
- Kivitz, Alan J.;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Xia, Katrina;
- Emoto, Kahaku;
- Kano, Shungo;
- Hendrikx, Thijs K.;
- Landewé, Robert B. M.;
- Aletaha, Daniel
Publication type:
Correction Notice
Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials.
Published in:
Rheumatology & Therapy, 2023, v. 10, n. 1, p. 161, doi. 10.1007/s40744-022-00503-3
By:
- Tanaka, Yoshiya;
- Atsumi, Tatsuya;
- Aletaha, Daniel;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Han, Ling;
- Emoto, Kahaku;
- Kano, Shungo;
- Rajendran, Vijay;
- Takeuchi, Tsutomu
Publication type:
Article
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
Published in:
Rheumatology & Therapy, 2023, v. 10, n. 1, p. 53, doi. 10.1007/s40744-022-00498-x
By:
- Combe, Bernard G.;
- Tanaka, Yoshiya;
- Buch, Maya H.;
- Nash, Peter;
- Burmester, Gerd R.;
- Kivitz, Alan J.;
- Bartok, Beatrix;
- Pechonkina, Alena;
- Xia, Katrina;
- Emoto, Kahaku;
- Kano, Shungo;
- Hendrikx, Thijs K.;
- Landewé, Robert B. M.;
- Aletaha, Daniel
Publication type:
Article

Found: 11